Article
[Analysis of decrease in sensitivity in influenza A (H5N1) avian and human strains to neuraminidase inhibitors].
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 1 Mar 2008
Reina J
Abstract excerpt
The options for efficient control of avian influenza A (H5N1) viruses include specific vaccination and antiviral prophylaxis and treatment. However, because H5N1 viruses undergo continuous antigen mutations, the production of a matched vaccine strain is currently not possible. Thus, during the early pandemic period, specific control measures would rely solely on antiviral drugs. Now only neuraminidase inhibitors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
